Analysis of factors influencing skip lymphatic metastasis in pN2 non-small cell lung cancer

被引:0
|
作者
Li, Gui-Long [1 ]
Zhu, Yong [1 ]
Zheng, Wei [1 ]
Guo, Chao-Hui [1 ]
Chen, Chun [1 ]
机构
[1] Fujian Med Univ, Union Hosp, Dept Thorac Surg, Fuzhou 350001, Peoples R China
关键词
Lung cancer; lymph node; skip metastasis; NODE METASTASIS; THERAPY; STAGE;
D O I
10.1007/s11670-012-0273-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Although many clinical studies on skip lymphatic metastasis in non-small cell lung cancer have been reported, the risk factors for skip lymphatic metastasis are still controversy and debatable. This study investigated, by multivariate logistic regression analysis, the clinical features of skip metastasis to mediastinal lymph nodes (N-2) in non-small cell lung cancer (NSCLC) patients. Methods: We collected the clinicopathological data of 256 pN(2)-NSCLC patients who underwent lobectomy plus systemic lymph node dissection in Fujian Medical University Union Hospital. The cases in the present study were divided into two groups: skip metastasis (N-2 skip+) and non- skip metastasis (N-2 skip-). A retrospective analysis of clinical pathological features of two groups was performed. To determine an independent factor, multivariate logistic regression analysis was used to identify possible risk factors. Results: A total of 256 pN(2)-NSCLC patients were recruited. The analysis results showed that gender, pathologic types, surgery, pleural involvement, smoking history, age, tumor stages, and differentiation were not statistical significant factors impacting on skip metastasis in pN(2)-NSCLC (P>0.05), whereas tumor size was an independent factor for skip metastasis (P=0.02). Conclusions: The rate of skip lymphatic metastasis increases in pN(2)-NSCLC patients, in accompany with an increased tumor size.
引用
收藏
页码:340 / 345
页数:6
相关论文
共 50 条
  • [31] Supraclavicular Recurrence in Completely Resected (y)pN2 Non-Small Cell Lung Cancer: Implications for Postoperative Radiotherapy
    Liu, Liang
    Zheng, Zhiqin
    Li, Juan
    Li, Yuan
    Ni, Jianjiao
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [32] Clinical implications of the pattern of recurrence of pN2 non-small-cell lung cancer
    Ding, Qifeng
    Shu, Jian
    Xu, Xuejun
    Chen, Yongbing
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2021, 59 (04) : 925 - 926
  • [33] Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma
    Benoit, L.
    Anusca, A.
    Ortega-Deballon, P.
    Cheynel, N.
    Bernard, A.
    Favre, J. P.
    EJSO, 2006, 32 (05): : 583 - 587
  • [34] The Role of Postoperative Radiation Therapy for pN2 Non-small-cell Lung Cancer
    Mankuzhy, Nikhil P.
    Almahariq, Muayad F.
    Siddiqui, Zaid A.
    Thompson, Andrew B.
    Grills, Inga S.
    Guerrero, Thomas M.
    Lee, Kuei C.
    Stevens, Craig W.
    Quinn, Thomas J.
    CLINICAL LUNG CANCER, 2021, 22 (01) : E5 - E17
  • [35] Lobe-Specific Skip Nodal Metastasis in Non-Small Cell Lung Cancer Patients
    Kawano, Ryoji
    Hata, Enjo
    Ikeda, Shingo
    Yokota, Toshiya
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2008, 14 (01) : 9 - 14
  • [36] Prognostic Factors for Brain Metastasis in Non-Small Cell Lung Cancer
    Duma, Narjust
    Sanchez, Laysa
    Miranda, Claudia
    Glisch, Chad
    Abu-Ihweij, Khaleb
    Zhang, Shijia
    Osorio, Carlos
    Listo, Matthew
    Harper, Harry D.
    Gutierrez, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S535 - S535
  • [37] Impact of Lymph Node Involvement and Tumor Location on Survival Following Resection for pN1/pN2 Non-Small Cell Lung Cancer
    Tsitsias, T.
    Saftic, I.
    Harling, L.
    Veres, L.
    King, J.
    Harrison-Phipps, K.
    Routledge, T.
    Pilling, J.
    Bille, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S547 - S548
  • [38] Prognostic factors for pN2 non-small cell lung cancer:a comprehensive evidence from 73 studies involving 23,772 patients
    Shuo Li
    Yanlin Feng
    Chunzi Liang
    Jiancheng Tu
    OncologyandTranslationalMedicine, 2020, 6 (02) : 57 - 63
  • [39] Micrometastasis and skip metastasis as predictive factors in non-small-cell lung cancer staging
    Baisi, Alessandro
    Raveglia, Federico
    De Simone, Matilde
    Cioffi, Ugo
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2013, 43 (05) : 1075 - 1075
  • [40] Adjuvant chemotherapy based on biochemical modulation against pathological stage IIIA pN2 non-small cell lung cancer
    Otake, Y
    Tanaka, F
    Oyanagi, H
    Katakura, H
    Kawano, Y
    Takata, T
    Nakagawa, T
    Matsuoka, K
    Miyahara, R
    Yanagihara, K
    Li, M
    Isowa, N
    Bando, T
    Hasegawa, S
    Inui, K
    Wada, H
    LUNG CANCER: CURRENT TOPICS, 2001, : 55 - 58